Evidence map

TrialDiabetes care2022

Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial.

Stephanie Kullmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

58 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34716213